1. Introduction

   • Ronald F. van Vollenhoven
   • Johan L. Severens

   Introduction 29 January 2011 Pages: 1 - 2

2. The burden of illness of rheumatoid arthritis

   • Annelies Boonen
   • Johan L. Severens

   Review 26 February 2011 Pages: 3 - 8

   

3. Introduction to economic modeling for clinical rheumatologists: application to biologic agents in rheumatoid arthritis

   • Carlo A. Marra
   • Nick Bansback
   • Kamran Shojania

   Review 26 February 2011 Pages: 9 - 18

   

4. Observational studies: a valuable source for data on the true value of RA therapies

   • Ronald F. van Vollenhoven
   • Johan L. Severens

   Review 22 December 2010 Pages: 19 - 24

   

5. The economic burden of rheumatoid arthritis: beyond health care costs

   • Wei Zhang
   • Aslam H. Anis

   OriginalPaper 02 March 2011 Pages: 25 - 32

   

6. The value of early intervention in RA—a window of opportunity

   • Ferdinand Breedveld

   Review 25 February 2011 Pages: 33 - 39

   

7. Predicting outcomes in rheumatoid arthritis

   • Philip G. Conaghan

   Review 04 January 2011 Pages: 41 - 47